In an emotional meeting, Oregon lawmakers consider requiring drug makers to list prices in ads
The House Committee on Health Care also took testimony on a bill that would require pharmacists to substitute brand name drugs with cheaper generics......»»
The Wall Street Journal: Drugmakers file lawsuit to block rule requiring drug prices in TV ads
Three pharmaceutic.....»»
Oregon Senate passes 60-day notice bill for drug price hikes
A bill requiring pharmaceutical manufacturers to give a 60-day notice of planned price increases for certain prescription drugs is heading to Gov. Kate Brown for her signature. House Bill 2658 passed the Oregon Senate on a unanimous vote, with fou.....»»
Next Avenue: Will drug prices in TV ads really be transparent?
The Trump administration is demanding list prices, but that’s often not what you pay......»»
Capitol Report: Could drug-price transparency raise prices? These lobbyists and lawmakers think so
As Washington tries to respond to calls for lower drug prices, even efforts to just bring more transparency to the state of affairs aren’t a slam dunk......»»
How the Trump prescription for drug prices transparency could make health care well again
Requiring pharmaceutical manufacturers to disclose drug costs in television ads might stimulate debate on .....»»
Want to Lower Drug Costs for Patients? Start With Rebates
Our current system encourages high list prices. No one should ever be forced to forgo or ration a .....»»
Oregon Legislature 2019: Host of health care bills survive key deadline
Bills to fund Medicaid, lower prescription drug prices, tighten vaccine exemptions and more are still alive......»»
Why the FDA is naming and shaming drugmakers
In its campaign to lower drug prices, the agency posted a list of brand-name manufacturers in an effort to force them to share drug samples with their generic rivals......»»
Why the FDA is naming and shaming drugmakers
In its campaign to lower drug prices, the agency posted a list of brand-name manufacturers in an effort to force them to share drug samples with their generic rivals......»»
FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs
InvestorPlace - Stock Market News, Stock Advice & Trading T.....»»
Despite pledge, 2 cancer drugs see major price hikes
Two weeks after President Trump in May unveiled a plan to lower drug prices for Americans, promising “it will start to take effect very soon,†the drug company Bayer hiked the list prices of two cancer drugs by more than $1,000 per month......»»
Pfizer"s not the only drug company raising prices
Pfizer caved to pressure from President Donald Trump to temporarily roll back its drug price increases. But the pharmaceutical company isn't the only one hiking list prices in recent months......»»
Merck to Limit Drug-Price Increases, Cut Some Prices
Merck & Co. said Thursday it will cut U.S. list prices for several of its drugs including the hepatitis C treatment Zepatier, and the company pledged to limit future net price increases......»»
​Meet the rebate, the new villain of high drug prices
Rebates, critics say, have pushed up the list price of brand-name drugs, which consumers are increasingly responsible for paying......»»
Feds say drugmakers' plan to disclose medicine prices doesn't go far enough
TV drug ads will direct patients to a website with medicine costs, including list prices, out-of-pocket costs and available financial a.....»»
Feds propose rules that would require drugmakers to disclose drug prices in TV ads
Federal health regulators proposed rules that would require drugmakers to disclose the list price of drugs in th.....»»
Trump’s Drug-Ad Price Shaming Won’t Fix the Problem
Transparency is a laudable goal, but a proposed rule to force disclosure of medicines’ list prices may only add to consumers’ confusion......»»
Drug Industry Pushes Back Against Required Listing of Prices in TV Ads
The pharmaceutical industry is signaling resistance to a Trump administration plan to require that the list price be included for most drugs in television ads, setting the stage for a protracted fight over a proposal with broad bipartisan support......»»
Viewpoint: It’s time to deep-six drug rebates
Now is the time to disrupt the method for pharmaceutical contracting in order to better control what many describe as egregious drug-pricing practices. We need to end the current practice of negotiating a discount taken off the list prices, which are se.....»»